Show items per page
Elements: 53
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? Calmy, Alexandra 2018
add to browser selection
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study Assoumou, Lambert; Descamps, Diane; Yerly Ferrillo, Sabine; Dos Santos, Georges; ... Masquelier, Bernard 2013
add to browser selection
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure Marcelin, Anne-Geneviève; Delaugerre, Constance; Beaudoux, Céline; Descamps, Diane; ... Flandre, Philippe 2013
add to browser selection
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients Calmy, Alexandra; Bel, Michael; Nguyen, A; Combescure, Christophe; ... Villard, Jean 2012
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
add to browser selection
Management of hepatitis C virus (HCV) infection in drug substitution programs Witteck, Andrea; Schmid, Patrick; Hensel-Koch, Katharina; Thurnheer, Maria C; ... Moradpour, D 2011
add to browser selection
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients Fattovich, Giovanna; Covolo, Loredana; Pasino, Michela; Perini, Eleonora; ... Donato, Francesco 2011
add to browser selection
Hepatitis D virus: an update Pascarella Rochat, Stéphanie; Negro, Francesco 2011
add to browser selection
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F 2011
add to browser selection
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. Bochud, Pierre-Yves; Bibert, Stéphanie; Negro, Francesco; Haagmans, B; ... Lagging, M 2011
add to browser selection
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C Sgier, C.; Mullhaupt, B.; Gerlach, T.; Moradpour, D.; ... Dufour, Jean-François 2010
add to browser selection
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia Simioni, Samanta; Cavassini, Matthias; Annoni, Gian-Maria; Rimbault Abraham, Aline; ... Du Pasquier, Renaud A. 2010
add to browser selection
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study Osih, Regina B.; Taffe, Patrick; Rickenbach, Martin; Gayet-Ageron, Angèle; ... Cavassini, Matthias 2010
add to browser selection
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy Rohrbach, Janine; Robinson, Nicola; Harcourt, Gillian; Hammond, Emma; ... Rauch, Andri 2010
add to browser selection
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study Gonvers, Jean-Jacques; Heim, Markus H.; Cavassini, Matthias; Mullhaupt, Beat; ... Oneta, Carl 2010
add to browser selection
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals Elzi, Luigia; Kaufmann, Gilbert; Weber, Rainer; Fux, C. A.; ... Battegay, Manuel 2009
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir Ananworanich, Jintanat; Gayet-Ageron, Angèle; Ruxrungtham, Kiat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard 2008
add to browser selection
Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy Ananworanich, Jintanat; Nuesch, Reto; Côté, Hélène C. F.; Kerr, Stephen J.; ... Hirschel, Bernard 2008
add to browser selection
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy Khanna, Nina; Opravil, Milos; Furrer, Hansjakob; Cavassini, Matthias; ... Kaufmann, Gilbert R. 2008
add to browser selection
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection Fätkenheuer, Gerd; Nelson, Mark; Lazzarin, Adriano; Konourina, Irina; ... van der Ryst, Elna 2008
add to browser selection
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial El-Sadr, W. M.; Grund, B.; Neuhaus, J.; Babiker, A.; ... Neaton, J. D. 2008
add to browser selection
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy Pugnale, Paolo; Herrmann, Eva; Neumann, Avidan U.; Pawlotsky, Jean-Michel; ... Negro, Francesco 2008
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Immunological recovery and antiretroviral therapy in HIV-1 infection Battegay, Manuel; Nuesch, Reto; Hirschel, Bernard; Kaufmann, G. R. 2006
add to browser selection
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study Zinkernagel, A. S.; von Wyl, Viktor; Ledergerber, Bruno; Rickenbach, Martin; ... Weber, Rainer 2006
add to browser selection
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads Benveniste, Olivier; Flahault, Antoine; Rollot, Florence; Elbim, Carole; ... Leport, Catherine 2005
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients Ananworanich, Jintanat; Hill, Andrew; Siangphoe, Umaporn; Ruxrungtham, Kiat; ... Hirschel, Bernard 2005
add to browser selection
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study Ananworanich, Jintanat; Siangphoe, Umaporn; Hill, Andrew; Cardiello, Peter; ... Ruxrungtham, Kiat 2005
add to browser selection
Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy Fischer, Marek; Joos, Beda; Wong, J. K.; Ott, Peter; ... Gunthard, Huldrych 2004
add to browser selection
Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation Giostra, Emiliano; Kullak-Ublick, Gerd A; Keller, Walter; Fried, Ronald; ... Negro, Francesco 2004
add to browser selection
Drug resistance mutations during structured treatment interruptions Yerly Ferrillo, Sabine; Fagard, Catherine; Gunthard, Huldrych; Hirschel, Bernard; Perrin, Luc 2003
add to browser selection
Beware of drug holidays before HIV salvage therapy Hirschel, Bernard 2003
add to browser selection
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART Fagard, Catherine; Le Braz, Michelle; Gunthard, Huldrych; Hirsch, H. H.; ... Hirschel, Bernard 2003
add to browser selection
Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS Challine, Dominique; Buisson, Marlyse; Cadilhac, Michel; Germanidis, Georgios; ... Seigneurin, Jean-Marie 2002
add to browser selection
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; ... Perrin, Luc 2002
add to browser selection
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy Oxenius, Annette; McLean, A. R.; Fischer, Marek; Price, D. A.; ... Gunthard, Huldrych 2002
add to browser selection
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load Oxenius, Annette; Price, D. A.; Dawson, S. J.; Gunthard, Huldrych; ... Phillips, R. E. 2002
add to browser selection
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort Hirschel, Bernard; Flepp, Markus; Bucher, H. C.; Zellweger, Claudine; ... Ledergerber, Bruno 2002
add to browser selection
A patient with HIV-1 superinfection Jost, Stéphanie; Bernard, Marie-Charlotte; Kaiser, Laurent; Yerly Ferrillo, Sabine; ... Perrin, Luc 2002
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
HIV transmission after suspension of highly active antiretroviral therapy Bernasconi, Enos; Vernazza, P. L.; Bernasconi, Alessandra; Hirschel, Bernard 2001
add to browser selection
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study Khanna, Nina; Klimkait, T.; Schiffer, V.; Irigoyen, J.; ... Battegay, M. 2000
add to browser selection
Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals Law, P; Lane, T A; Gervaix, Alain; Looney, D; ... Ho, A D 1999
add to browser selection
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation Negro, Francesco; Giostra, Emiliano; Rubbia-Brandt, Laura; Mentha, Gilles; ... Hadengue, Antoine 1998
<< previous | 1 | 2 |